NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MASI

Masimo Corp

Apr 29 • 04:00PM ET

163.14

Dollar change -0.90
Percentage change -0.55	%

Healthcare • Medical Devices • USA • NASD

Peers: MDT ABT TMO BSX EW GEHC ZBH HOLX NVCR BIO

| Held by: VTI IJH VB VXF VBK MDY IJK IHI SPMD IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.70	Insider Own	7.85%	Shs Outstand	53.60M	Perf Week	7.28%
Market Cap	8.82B	Forward P/E	27.72	EPS next Y	5.89	Insider Trans	-0.75%	Shs Float	49.80M	Perf Month	-0.25%
Income	-304.90M	PEG	-	EPS next Q	1.21	Inst Own	95.60%	Short Float	5.61%	Perf Quarter	-6.87%
Sales	2.09B	P/S	4.21	EPS this Y	19.24%	Inst Trans	-2.82%	Short Ratio	4.77	Perf Half Y	15.92%
Book/sh	19.62	P/B	8.31	EPS next Y	12.19%	ROA	-10.76%	Short Interest	2.79M	Perf Year	20.63%
Cash/sh	3.34	P/C	48.89	EPS next 5Y	14.67%	ROE	-25.23%	52W Range	101.61 - 194.88	Perf YTD	-1.31%
Dividend Est.	-	P/FCF	49.97	EPS past 5Y	-	ROI	-16.58%	52W High	-16.29%	Beta	1.22
Dividend TTM	-	Quick Ratio	1.24	Sales past 5Y	19.49%	Gross Margin	47.96%	52W Low	60.56%	ATR (14)	7.93
Dividend Ex-Date	Nov 23, 2012	Current Ratio	1.98	EPS Y/Y TTM	-467.23%	Oper. Margin	1.99%	RSI (14)	53.02	Volatility	3.54% 6.14%
Employees	9200	Debt/Eq	0.80	Sales Y/Y TTM	2.26%	Profit Margin	-14.56%	Recom	1.90	Target Price	199.29
Option/Short	Yes / Yes	LT Debt/Eq	0.75	EPS Q/Q	-1130.07%	Payout	-	Rel Volume	0.59	Prev Close	164.04
Sales Surprise	1.37%	EPS Surprise	26.32%	Sales Q/Q	9.44%	Earnings	May 06 AMC	Avg Volume	585.11K	Price	163.14
SMA20	4.46%	SMA50	-2.09%	SMA200	8.15%	Trades		Volume	343,388	Change	-0.55%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-27-24	Reiterated	Raymond James	Outperform	$170 → $194
Nov-06-24	Upgrade	Raymond James	Mkt Perform → Outperform	$170
Jun-03-24	Upgrade	Piper Sandler	Neutral → Overweight	$126 → $160
Apr-15-24	Upgrade	Stifel	Hold → Buy	$148 → $170
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$117 → $160
Jan-30-24	Downgrade	Jefferies	Buy → Hold	$107 → $121
Jan-03-24	Downgrade	Needham	Buy → Hold
Nov-08-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-18-23	Downgrade	Stifel	Buy → Hold	$205 → $120
Jul-10-23	Initiated	Wells Fargo	Equal Weight	$173
Feb-22-23	Upgrade	Raymond James	Mkt Perform → Outperform	$187
Dec-15-22	Upgrade	BTIG Research	Neutral → Buy	$180
Dec-05-22	Reiterated	Needham	Buy	$149 → $173
Oct-12-22	Initiated	Jefferies	Buy	$180
Sep-15-22	Upgrade	Wolfe Research	Peer Perform → Outperform	$165
Sep-14-22	Initiated	Loop Capital	Buy	$206
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$160
Feb-18-22	Upgrade	Needham	Hold → Buy	$205
Feb-16-22	Downgrade	Piper Sandler	Overweight → Neutral	$330 → $200
Oct-12-21	Resumed	Raymond James	Mkt Perform

Show Previous Ratings

Today 01:10PM	ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates (Zacks)
11:45AM	Baron Health Care Fund Q1 2025 Top Net Purchases And Sales (Seeking Alpha)
09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Apr-28-25 01:26PM	EMEA Growth & Product Launches to Support Boston Scientific Stock (Zacks)
01:18PM	RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up (Zacks)
11:24AM	Loading…
11:24AM	Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y (Zacks)
09:19AM	HSIC Gears Up for Q1 Earnings: Here's What You Need to Know (Zacks)
Apr-27-25 02:22PM	Baron Health Care Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-25-25 12:50PM	Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now (Zacks)
12:48PM	Integer Holdings Q1 Earnings & Revenues Beat Estimates, Margins Expand (Zacks)
10:18AM	CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
10:02AM	Masimo: Priced Dearly Given Uncertainty (Seeking Alpha)
Apr-24-25 01:02PM	Here's Why You Should Add Veeva Stock to Your Portfolio Now (Zacks)
11:39AM	EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes (Zacks)
11:36AM	WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit (Zacks)
10:42AM	Loading…
10:42AM	Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand (Zacks)
09:00AM	Masimo to Report First Quarter 2025 Financial Results after Market Close on Tuesday, May 6 (Business Wire)
07:25AM	AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise (Zacks)
07:24AM	ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market (Zacks)
06:43AM	EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised (Zacks)
Apr-23-25 12:53PM	Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up (Zacks)
12:39PM	ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts (Zacks)
09:47AM	BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised (Zacks)
Apr-22-25 11:34AM	Concentra Stock Slips Despite Deal to Acquire Pivot Onsite Innovations (Zacks)
10:34AM	Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up (Zacks)
08:13AM	Zimmer Biomet to Report Q1 Earnings: Here's What to Expect (Zacks)
07:29AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Apr-21-25 11:08AM	ECL Stock Gains Following 5% Trade Surcharge in the United States (Zacks)
08:34AM	IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? (Zacks)
Apr-18-25 12:10PM	Why Masimo (MASI) Could Beat Earnings Estimates Again (Zacks)
10:27AM	Loading…
Apr-17-25 10:27AM	Why You Shouldn't Bet Against Masimo (MASI) Stock (Zacks)
09:12AM	Should You Continue to Hold Veracyte Stock in Your Portfolio? (Zacks)
09:00AM	Reasons to Hold TNDM Stock in Your Portfolio for Now (Zacks)
08:53AM	ALGN Gears Up for Q1 Earnings: What Lies Ahead for the Stock? (Zacks)
08:31AM	Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings (Zacks)
Apr-16-25 01:15PM	Will a Strong MA Business Aid Elevance Health's Q1 Earnings? (Zacks)
01:07PM	Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market (Zacks)
10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
10:21AM	Is it the Right Time to Hold STERIS Stock in Your Portfolio? (Zacks)
10:17AM	Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth (Zacks)
09:21AM	Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now (Zacks)
09:01AM	3 Healthcare Stocks Facing Headwinds (StockStory)
07:32AM	Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings (Zacks)
07:13AM	LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 (Zacks)
07:10AM	Here's Why You Should Retain Inogen Stock in Your Portfolio Now (Zacks)
Apr-15-25 11:20AM	HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold? (Zacks)
11:04AM	Merit Medical Stock Slips Despite the Launch of New Ventrax System (Zacks)
09:28AM	Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings (Zacks)
Apr-14-25 09:39AM	Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler (Zacks)
Apr-11-25 01:01PM	DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance (Zacks)
12:15PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
06:45AM	DGX Stock Gains Following the Launch of New AD-Detect Blood Test (Zacks)
12:30AM	Harbor Health Care ETF Q4 2024 Commentary (Seeking Alpha)
Apr-10-25 08:52AM	Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus (Zacks) -7.95%
07:29AM	Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract (Zacks)
07:25AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
07:16AM	Should You Continue to Hold NVST Stock in Your Portfolio? (Zacks)
Apr-09-25 01:35PM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks) +13.45%
01:30PM	Telix Shares May Gain on the Distribution Deal With Cardinal Health (Zacks)
09:52AM	Is it the Right Time to Retain Labcorp Stock in Your Portfolio? (Zacks)
09:45AM	Here's Why Masimo (MASI) is a Strong Growth Stock (Zacks)
07:26AM	Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down (Zacks)
06:33AM	ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts (Zacks)
Apr-08-25 11:57AM	GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform (Zacks)
10:02AM	PODD Stock Benefits From the Launch of Omnipod 5 in Canada (Zacks)
06:46AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
06:46AM	BD Seeks Potential Buyers for Life Sciences Business Division (Zacks)
05:04AM	Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI) (StockStory)
Apr-07-25 12:15PM	ZBH Stock to Gain From Volume Growth Amid Rising Costs (Zacks)
08:37AM	GMED Stock May Benefit Following the Acquisition of Nevro (Zacks)
07:45AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
Apr-04-25 12:37PM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks) -5.23%
12:36PM	SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System (Zacks)
08:06AM	RMD Stock Benefits From the Launch of NightOwl Across US (Zacks)
08:06AM	Here's Why You Should Retain DexCom Stock in Your Portfolio for Now (Zacks)
Apr-03-25 03:00PM	MCK Stock Gains as PRISM Acquisition Adds High-Growth Business (Zacks) -11.14%
01:25PM	Global Expansion in EPD and Innovations Support Abbott Stock (Zacks)
01:16PM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
01:13PM	AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands (Zacks)
10:38AM	Medical Device Stocks Fall on Tariff Hit (The Wall Street Journal)
07:56AM	ALC Stock May Rise With the Introduction of PanOptix Pro in US (Zacks)
07:54AM	AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK (Zacks)
Apr-02-25 03:00PM	MIST Stock Falls 66% Following Complete Response Letter for Cardamyst (Zacks)
02:00PM	3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes (Zacks)
12:45PM	Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
10:10AM	VEEV Stock Slips Despite New Research Site Clinical Trial System (Zacks)
09:00AM	Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
07:47AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:47AM	ALGN Stock Gains From the Invisalign System With Mandibular Advancement (Zacks)
Apr-01-25 12:41PM	GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech (Zacks)
07:22AM	ABT Stock Gains Following the Positive TRILUMINATE Trial Results (Zacks)
07:21AM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
09:35AM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
09:16AM	IceCure Medical Stock Dips Despite Positive ICESECRET Study Results (Zacks)
Mar-27-25 12:01PM	International Expansion, Product Launches Support BSX Stock (Zacks)
11:30AM	Masimo (MASI) Down 12.6% Since Last Earnings Report: Can It Rebound? (Zacks)
10:48AM	Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win (Zacks)
10:29AM	Here's Why You Should Hold AVTR Stock in Your Portfolio for Now (Zacks)
09:07AM	Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock? (Zacks)

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McClenahan Thomas Samuel	Former Officer	Apr 24 '25	Proposed Sale	162.95	26,300	4,285,475		Apr 24 04:20 PM
REYNOLDS CRAIG B	Director	Mar 14 '25	Sale	166.13	2,053	341,068	16,581	Mar 14 05:24 PM
REYNOLDS CRAIG B	Director	Mar 14 '25	Proposed Sale	166.13	2,053	341,068		Mar 14 04:10 PM
Muhsin Bilal	Chief Operating Officer	Mar 10 '25	Option Exercise	37.84	30,000	1,135,200	54,172	Mar 12 08:05 PM
Muhsin Bilal	Chief Operating Officer	Mar 10 '25	Sale	167.49	30,000	5,024,585	24,172	Mar 12 08:05 PM
Muhsin Bilal	Officer	Mar 10 '25	Proposed Sale	167.48	30,000	5,024,549		Mar 10 05:12 PM
Tripodi Blair	COO, Consumer Division	Mar 01 '25	Option Exercise	0.00	15,000	0	15,000	Mar 04 04:52 PM
Muhsin Bilal	Chief Operating Officer	Mar 01 '25	Option Exercise	0.00	15,000	0	32,270	Mar 04 04:48 PM
Young Micah W	EVP & Chief Financial Officer	Mar 01 '25	Option Exercise	0.00	15,000	0	25,536	Mar 04 04:44 PM
McClenahan Thomas Samuel	Officer	Mar 03 '25	Proposed Sale	191.13	49,000	9,365,578		Mar 03 04:44 PM
Levy Tao	Former Affiliate	Feb 28 '25	Proposed Sale	187.67	36,537	6,856,889		Mar 03 01:26 PM
KIANI JOE E	Former Affiliate	Jan 07 '25	Proposed Sale	165.65	302,165	50,052,375		Jan 07 05:36 PM
Levy Tao	Former Affiliate	Dec 16 '24	Proposed Sale	176.73	15,072	2,663,664		Dec 16 04:09 PM
Levy Tao	EVP, Bus Dev	Nov 13 '24	Option Exercise	0.00	30,000	0	41,208	Nov 15 06:05 PM
Politan Capital Management LP	Director by deputization	Jun 26 '24	Option Exercise	0.00	1,228	0	4,714,746	Sep 23 06:31 PM
Brennan Michelle	Director	Jun 26 '24	Option Exercise	0.00	1,228	0	1,228	Sep 23 06:22 PM
KIANI JOE E	CEO and Chairman of the Board	Aug 08 '24	Option Exercise	37.84	231,748	8,769,344	603,924	Aug 12 09:59 PM
REYNOLDS CRAIG B	Director	May 01 '24	Option Exercise	23.04	10,000	230,400	17,406	May 03 05:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MASI

Masimo Corp

Upgrade your FINVIZ experience